Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Bridging data and discovery: a survey on knowledge graphs in AI for science.

National science review·2026

Same author

Simultaneous In-Depth Single-Cell Proteomic and Metabolomic Analysis.

Analytical chemistry·2026

Same author

Rapid Microfluidic Drug Sensitivity Testing Within 5 Days Using Minimal Clinical Tumor Samples.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

Same author

[Determination of 26 herbicide residues in soil， sediment， and surface water samples using modified QuEChERS method combined with ultra-high performance liquid chromatography-tandem mass spectrometry].

Se pu = Chinese journal of chromatography·2025

Same author

Benchmarking informatics workflows for data-independent acquisition single-cell proteomics.

Nature communications·2025

Same author

[Correlation between Expression Levels of Tim-3, <i>C-myc</i> and Proportion of T Lymphocyte Subsets and Prognosis in Patients with Acute Lymphoblastic Leukemia].

Zhongguo shi yan xue ye xue za zhi·2025

Search research articles

Related Experiment Video

Updated: Sep 16, 2025

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Published on: June 30, 2017

Integrated Single-Cell Proteomic and Morphometric Analysis Reveals Heterogeneous Drug-Resistant Subpopulations.

Qian-Xi Fan¹, Yi-Rong Jiang¹, Jian-Bo Chen¹

¹Institute of Microanalytical Systems, Department of Chemistry, Zhejiang University, Hangzhou 310058, China.

Analytical Chemistry

|July 7, 2025

Summary

This summary is machine-generated.

Understanding cancer drug resistance requires studying individual cell responses. A new platform integrates single-cell proteomics and cell morphology to reveal drug-resistant cancer cell subpopulations and their unique patterns.

More Related Videos

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Related Experiment Videos

Last Updated: Sep 16, 2025

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Discrimination and Characterization of Heterocellular Populations Using Quantitative Imaging Techniques

Published on: June 30, 2017

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms

Published on: December 9, 2015

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

Area of Science:

Biochemistry
Cell Biology
Cancer Research

Background:

Investigating heterogeneous cancer cell responses to chemotherapy is vital for understanding drug resistance mechanisms.
Single-cell proteomics offers powerful insights into cellular drug responses.
Linking cellular morphology to drug resistance is an emerging area, but integrating these data remains challenging.

Purpose of the Study:

To develop and present a novel morphology-aware single-cell proteomic analysis (Morp-SCP) platform.
To integrate high-resolution imaging with deep proteomic analysis at the single-cell level.
To provide multidimensional data for understanding single-cell heterogeneity in drug response.

Main Methods:

Development of the Morp-SCP platform for real-time, high-resolution cell imaging and capture.
Application of Morp-SCP to analyze time-dependent proteomic alterations in human nonsmall cell lung cancer cells (A549) exposed to cisplatin.
Deep proteomic analysis of single cells identified through imaging.

Main Results:

Identification of distinct subpopulations of cisplatin-resistant A549 cells.
Characterization of unique proteomic and morphological patterns in drug-resistant subpopulations.
Demonstration of a correlation between proteomics and morphology in single cancer cells resisting chemotherapy.

Conclusions:

The Morp-SCP platform effectively integrates proteomic and morphological data for single-cell analysis.
This approach reveals insights into the heterogeneity of cancer drug resistance at the single-cell level.
The findings highlight the potential of morphology-aware single-cell proteomics in cancer research and drug development.